We are live on ! Find out more
ORIC icon

Oric Pharmaceuticals
ORIC

101 hedge funds and large institutions have $182M invested in Oric Pharmaceuticals in 2022 Q1 according to their latest regulatory filings, with 33 funds opening new positions, 22 increasing their positions, 28 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 33 | Existing positions closed: 12

26% more funds holding

Funds holding: 80 → 101 (+21)

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

2.24% less ownership

Funds ownership: 88.52% → 86.27% (-2.2%)

21% less repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 28

65% less capital invested

Capital invested by funds: $512M → $182M (-$330M)

Holders
101
Holders Change
+21
Holders Change %
+26.25%
% of All Funds
1.59%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
33
Increased
22
Reduced
28
Closed
12
Calls
$1.1M
Puts
–
Net Calls
+$1.1M
Net Calls Change
+$1.1M

Top Buyers

1
First Manhattan
First Manhattan
New York
+$17.6M
2
BC
Boxer Capital
California
+$7.69M
3
Alkeon Capital Management
Alkeon Capital Management
New York
+$4.32M
4
Millennium Management
Millennium Management
New York
+$3.4M
5
Two Sigma Investments
Two Sigma Investments
New York
+$2.88M

Top Sellers

1
Victory Capital Management
Victory Capital Management
Texas
-$15.8M
2
Jennison Associates
Jennison Associates
New York
-$14.5M
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$13.4M
4
State Street
State Street
Massachusetts
-$6.11M
5
ACH
ArrowMark Colorado Holdings
Colorado
-$5.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
VOYA Investment Management
76
VOYA Investment Management
Georgia
$64K -$497K -55,238 -82%
CC
77
Corton Capital
Ontario, Canada
$56K -$57.7K -6,411 -38%
VF
78
Virtu Financial
New York
$56K +$95K +10,548 New
Ensign Peak Advisors
79
Ensign Peak Advisors
Utah
$55K – – –
Legal & General Group
80
Legal & General Group
United Kingdom
$51K – – –
Point72 Asset Management
81
Point72 Asset Management
Connecticut
$42K +$70.2K +7,800 New
Citigroup
82
Citigroup
New York
$32K -$498K -55,291 -90%
Barclays
83
Barclays
United Kingdom
$29K +$47.3K +5,252 New
Acadian Asset Management
84
Acadian Asset Management
Massachusetts
$29K +$49.6K +5,507 New
PHK
85
Point72 Hong Kong
Hong Kong
$24K +$40.8K +4,532 New
AB
86
Amalgamated Bank
New York
$22K +$36.3K +4,028 New
AF
87
Amalgamated Financial
New York
$22K +$36.3K +4,028 New
Royal Bank of Canada
88
Royal Bank of Canada
Ontario, Canada
$21K -$19.4K -2,157 -35%
AIP
89
Ameritas Investment Partners
Nebraska
$12K – – –
CAPTRUST Financial Advisors
90
CAPTRUST Financial Advisors
North Carolina
$10K +$17K +1,884 New
Simplex Trading
91
Simplex Trading
Illinois
$9K +$16.7K +1,852 New
Canada Life
92
Canada Life
Manitoba, Canada
$8K – – –
Russell Investments Group
93
Russell Investments Group
United Kingdom
$5K – – –
Federated Hermes
94
Federated Hermes
Pennsylvania
$3K +$4.56K +506 New
Daiwa Securities Group
95
Daiwa Securities Group
Japan
$1K – – –
FCA
96
FinTrust Capital Advisors
South Carolina
$1K +$901 +100 New
Osaic Holdings
97
Osaic Holdings
Arizona
$1K +$2.38K +264 New
Macquarie Group
98
Macquarie Group
Australia
$2 – – –
Jennison Associates
99
Jennison Associates
New York
– -$14.5M -985,072 Closed
Rafferty Asset Management
100
Rafferty Asset Management
New York
– -$1.01M -68,423 Closed
1 2 3
4
5

ORIC Hedge Fund Activity: Q1 2022 in Review

101 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Oric Pharmaceuticals (ORIC) for Q1 2022, worth a combined $182M — down 65% from $512M a quarter earlier.

Buyers outnumbered sellers: 33 funds opened new ORIC positions and 12 closed out — a net gain of 21 holders — while 22 added to existing stakes and 28 trimmed.

The largest buyer was First Manhattan, opening a new position worth an estimated $17.6M. The largest seller was Victory Capital Management, cutting an estimated $15.8M.

  • 101 institutional investors held Oric Pharmaceuticals (ORIC) as of Q1 2022, up from 80 in Q4 2021.
  • Funds reported $182M of Oric Pharmaceuticals stock for Q1 2022, down 65% quarter-over-quarter.
  • 33 funds opened new Oric Pharmaceuticals positions in Q1 2022 and 12 closed out, a net change of +21 holders.
  • The largest Oric Pharmaceuticals buyer in Q1 2022 was First Manhattan, an estimated $17.6M added.
  • The largest Oric Pharmaceuticals seller in Q1 2022 was Victory Capital Management, an estimated $15.8M sold.

Based on aggregated 13F filings for Q1 2022.